Skip to main content

Table 2 Clinical baseline

From: Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment

Demographics Patients with AMH > 10th centile (n = 847) Patients with AMH ≤ 10th centile (n = 62)  
Female age, yrs 33.3 ± 5.0 33.8 ± 5.0 0.46
BMI, kg/m2 21.6 ± 2.9 21.6 ± 2.8 0.99
Duration of infertility, months 39 ± 32 40 ± 31 0.82
Menstrual period, days 30 ± 4 28 ± 3 0.003
Women with prior live birth, n (%) 202 (23.8%) 14 (22.6%) 0.46
Regular menstruation 728 (86%) 56 (90.3) 0.34
Ovary surgery history, n (%) 68 (8%) 4 (6.5%)  
Causes for infertility, n (%)    < 0.01
 Tubal factor 359 (42.4%) 4 (6.5%)  
 DOR 80 (9.4%) 55 (88.7%)  
 PCOS 106 (12.5%) 0  
 Endometriosis 61 (7.2%) 1 (1.6%)  
 Adenomyosis 12 (1.4%) 0  
 Male factor 173 (20.4%) 1 (1.6%)  
 Combined 19 (2.2%) 1 (1.6%)  
 Unexplained 37 (4.4%) 0  
AMH, ng/ml 3.8 ± 3.2 0.4 ± 0.3 < 0.01
FSH, IU/L 7.8 ± 3.4 14.7 ± 7.9 < 0.01
AFC 12 ± 7 5 ± 2 < 0.01
  1. BMI Body mass index, DOR Decreased ovarian reserve, PCOS Polycystic ovary syndrome, AMH Anti-Mullerian hormone, FSH Follicle stimulation hormone, AFC Antral follicle count